Warning letter woes: Dr Reddy's expects FDA inspection of AP plant by year-end

USFDA had issued warning letter in November 2015 relating to Current
Good Manufacturing Practice deviations at DR Reddy's API manufacturing
facilities at Srikakulam.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/warning-letter-woes-dr-reddys-expects-fda-inspection-of-ap-plant-by-year-end/articleshow/70447944.cms

Comments

Popular posts from this blog

Sunday Worship Service

Teva Regulatory Affairs Associate Job Vacancy – Apply Online

Teva Regulatory Affairs Job Vacancy – Pharma Candidates Apply